Search clinical trials for: esomeprazole or pantoprazole

Total 6655 results

LCMC Health

Terminated

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection (CENERDD)

Gastroesophageal Reflux | Non-erosive Reflux Disease

United States
IBSA Institut Biochimique SA

Completed

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Hypothyroidism;Postablative

United States
West China Hospital

Not yet recruiting

Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

Upper Gastrointestinal Hemorrhage
AstraZeneca

Completed

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Gastroesophageal Reflux Disease

United States, Puerto Rico
Meridian Bioscience, Inc.
Rabin Medical Center

Completed

13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

Helicobacter Pylori Infection

Israel
King Saud University

Completed

Prophylaxis for Aspiration of Gastric Contents.

Pulmonary Aspiration of Gastric Contents
Temple University

Withdrawn

Comparison of Voice Therapy and Antireflex Therapy in LPR

Laryngopharyngeal Reflux

United States
Effexus Pharmaceutical
Southern Arizona VA Health Care System

Unknown

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Heartburn | Gastroesophageal Reflux Disease (GERD) | Indigestion

United States
Seoul National University Hospital
Dong-A ST Co., Ltd.

Not yet recruiting

Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19

COVID-19

Korea, Republic of
Centre de Recherche de l'Institut Universitaire...

Completed

Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects (SPICE)

Coronary Artery Disease

Canada
Takeda

Completed

Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease (PAMES 0109)

GERD

Brazil
American University of Beirut Medical Center
AstraZeneca

Completed

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

Calcium Metabolism Disorders

Lebanon
National Cheng-Kung University Hospital
National Science Council, Taiwan

Completed

The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers (CSE)

Peptic Ulcer Hemorrhage

Taiwan
AstraZeneca

Completed

Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

Healthy

United States
Casa Sollievo della Sofferenza IRCCS

Completed

High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding

Upper Gastrointestinal Bleeding | Peptic Ulcers

Italy
National Taiwan University Hospital

Unknown

Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis

Peptic Ulcers

Taiwan
Changhua Christian Hospital

Withdrawn

Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)

Upper Gastrointestinal Bleeding
AstraZeneca

Completed

Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

Healthy

United States
AstraZeneca

Completed

A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients

Nausea | Heartburn | Acid Regurgitation | Upper Abdominal Pain
University of Florida
Bristol-Myers Squibb; Sanofi

Completed

PPI and Clopidogrel Response

Drug Interaction

United States
Queen's University
Canadian Institutes of Health Research (CIHR)

Terminated

Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

Gastric Acid

Canada
AstraZeneca

Completed

Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

Gastrointestinal Hemorrhage

China
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Asan Medical Center

Completed

Helicobacter Pylori and Proton Pump Inhibitor

Helicobacter Infections

Korea, Republic of
Future University in Egypt
Ain Shams University; Nasser Institute For Research and Treatment

Completed

Esomeprazole or Pantoprazole in Renal Transplantation

Kidney Transplant; Complications
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Proton Pump Inhibitors and Risk of Community-acquired Pneumonia

Gastroesophageal Reflux Disease (GERD) | Community-acquired Pneumonia

Canada
University of Roma La Sapienza

Unknown

"Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER- (dOPPLER)

Coronary Artery Disease

Italy
Hanmi Pharmaceutical Company Limited

Unknown

Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

Healthy

Korea, Republic of
Bayer

Completed

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

Human Experimentation
Victoria Rollason

Active, not recruiting

PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms (PROGRESS)

Stomach Diseases

Switzerland
AstraZeneca

Completed

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease | Heartburn
Changi General Hospital

Unknown

A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis (TRIVON)

Helicobacter Pylori Infection

Singapore
Lotung Poh-Ai Hospital
Tomorrow Medical Foundation

Withdrawn

Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

Peptic Ulcer
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

Gastroesophageal Reflux Disease
Erasmus Medical Center

Completed

The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib (REGORA)

Colorectal Neoplasms | Gastrointestinal Stromal Tumors

Netherlands
National Institute of Diabetes and Digestive and...

Completed

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

Gastrinoma | Zollinger Ellison Syndrome

United States
Capital Medical University

Unknown

A New System for GERD Diagnosis and Treatment (EAISMLP)

GERD
EMS

Completed

Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

Dyspepsia | Acute and Chronic Inflammation

Brazil
University of Malaya

Recruiting

Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian Patients

Functional Dyspepsia

Malaysia
AstraZeneca

Completed

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

Barrett's Esophagus

United States
Mahidol University
Ramathibodi Hospital

Completed

Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura

Chronic Idiopathic Thrombocytopenic Purpura | Helicobacter Pylori Infection

Thailand
Shinshu University

Recruiting

Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers

Gastrointestinal Erosions and/or Ulcers

Japan
Procter and Gamble

Completed

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Healthy

United States
National Taiwan University Hospital
Haemonetics Corporation

Unknown

Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

30 Healthy People

Taiwan
Yaling Han

Unknown

Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)

Acute Coronary Syndromes

China
AstraZeneca

Completed

A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis

Erosive Esophagitis
AstraZeneca

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Erosive Esophagitis
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Maintenance Treatment)

Reflux Esophagitis

Japan
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Initial Treatment)

Reflux Esophagitis

Japan
Sheba Medical Center

Withdrawn

Clopidogrel Proton-Pump Inhibitors Study

Coronary Artery Disease

Israel

3

Subscribe